查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853771

放射治疗设备市场按技术、最终用户和应用划分－2025-2032年全球预测

Radiation Therapy Equipment Market by Technology, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，放射治疗设备市场规模将达到 146.3 亿美元，复合年增长率为 7.37%。

关键市场统计数据
基准年 2024 82.8亿美元
预计年份：2025年 88.9亿美元
预测年份 2032 146.3亿美元
复合年增长率 (%) 7.37%

简要介绍影响放射治疗设备采购和实施的临床、技术和营运力量的融合。

在影像技术、计画演算法和治疗平台进步的推动下，放射肿瘤学领域正经历着技术革新和临床整合的快速发展时期。治疗机构优先考虑能够提高治疗精度、缩短治疗时间并与多学科治疗路径整合的设备。随着医疗服务模式转向价值导向模式，临床团队需要的设备不仅要满足严格的疗效和安全性标准，还要能够提高工作流程效率并改善病患体验。在资金分配日益紧缩和监管审查不断加强的背景下，策略采购决策越来越关注设备的生命週期可维护性、互通性和可证实的临床效益。

同时，研究计画和学术中心不断突破治疗模式的界限，探索剂量递增策略、适应性治疗方法和新型粒子的治疗潜力。这种研究势头得益于患者群体和转诊医生对治疗效果和毒性缓解措施的日益了解，他们期望获得清晰的证据。鑑于这些动态，管理人员和临床领导者在评估升级或新设备的实施时，必须权衡技术能力、营运准备和报销现实。临床目标与设备选择之间的明确一致性将决定医疗机构能否在保持财务永续性的同时最大限度地提高临床疗效。

自我调整成像、紧凑型交付平台、人工智慧驱动的规划和服务弹性如何重塑临床路径和采购重点

多项变革性变化正在重塑放射治疗生态系统，并改变治疗的规划、实施和评估方式。首先，影像引导和自适应放射治疗工作流程的成熟，使得高度个人化的治疗成为可能，能够根据治疗过程中解剖结构的变化进行调整，从而改变了对设备的要求以及对整合影像处理功能的需求。其次，紧凑型、成本优化的平台的出现，扩大了社区的治疗覆盖范围，并刺激了基于设备价格、服务模式和总体拥有成本等方面的竞争。

第三，计算技术的进步，特别是自动化治疗计划和人工智慧辅助勾画，正在改变医疗专业人员的技能组合，并凸显了供应商提供软体更新和检验框架的必要性。第四，以患者为中心的治疗设计和低分割放射治疗方案提高了对治疗效率的预期，迫使医疗机构在速度和准确性之间寻求平衡。最后，随着医疗机构优先考虑执行时间和可预测的维护成本，供应链韧性和售后服务策略变得日益重要。为了维持临床相关性和营运效率，相关人员被迫重新评估临床路径、采购标准和供应商伙伴关係。

评估近期关税政策对您营运的影响，并考虑如何减轻对供应链多元化和本地定序策略的干扰。

贸易政策调整带来的新关税措施，为医疗服务提供者和技术供应商带来了一系列营运方面的考量。部分零件和整套放射治疗系统的进口关税会增加海外製造或依赖国际采购子系统的设备的购买成本。为此，采购团队正在重新评估整体拥有成本，并强调模组化架构的重要性，这种架构允许逐步升级、本地维护和零件互换，从而降低跨境价格波动带来的风险。

製造商和经销商正在透过供应商网路多元化、尽可能实现最终组装本地化以及重新谈判服务合约来适应变化，从而为客户维持可预测的生命週期经济效益。因此，临床规划人员和资本委员会必须预见某些配置的前置作业时间将会延长，并优先考虑与现有基础设施的兼容性，以避免代价高昂的维修。从正面来看，关税可能会加速加强国内製造能力和售后市场生态系统的策略，从而为本地维护点和培训专案创造机会。最终，这些贸易措施的累积影响将波及采购时间表、供应商选择框架和长期维护计划，需要临床、财务和供应链相关人员的协调应对。

优先考虑投资和营运规划，并利用关键的细分洞察，将技术模式、医疗服务环境和临床应用连结起来。

了解技术、最终用户和应用领域的细分，能够为评估产品开发优先顺序和推广路径提供结构化的视角。在考虑各种技术时，例如近距离放射治疗（区分高剂量率和低剂量率方法）、直线加速器、质子治疗和立体定位系统（区分高能量和低能量配置），每种技术都呈现不同的临床权衡和资本投入。这些技术差异不仅影响临床适应症，还影响屏蔽、影像整合和房间占用等基础设施需求，进而影响部署时间表和跨专业协作需求。

从最终用户的观点，门诊手术中心（包括医院附属中心和独立中心）的人员配备、报销和容量模式与癌症研究中心不同。癌症研究中心又可进一步细分为政府和私人研究机构，以及私立和公立医院，它们的采购管理和预算週期也各不相同。这些差异影响着采购考量、预期服务水准和培训投入。针对不同疾病部位的应用细分，例如管治和神经系统治疗（传统放射疗法和立体定位放射放射线手术发挥不同的作用）、乳癌（采用外照射和术中策略）、肺癌（采用外照射和立体定位放射治疗）以及摄护腺癌（采用近距离放射治疗和外治疗方法），可以明确临床工作流程的影响以及设备功能的优先顺序。将技术映射到最终用户和应用场景，可以揭示在哪些方面最需要整合、临床证据生成和专业服务支持，从而推动技术应用并优化患者预后。

报销、基础设施投资和服务网络如何影响美洲、欧洲、中东和非洲以及亚太地区的设备采用和伙伴关係模式

区域动态影响全球范围内的应用模式、监管路径和伙伴关係模式。在美洲，报销机制、先进癌症中心的集中以及医院系统整合的趋势，都在推动可扩展、高通量平台的需求，以支持复杂的适应症。该地区也高度重视服务网路和对设备故障的快速反应，这影响着供应商的选择和售后市场策略。

在欧洲、中东和非洲，不同的监管环境和基础设施投资水准导致了不同的技术采纳曲线。高所得市场优先考虑尖端治疗方法，而资源匮乏地区则更注重成本效益高、经久耐用的平台和强大的本地服务支援。跨境监管协调工作和区域卓越中心促进了知识转移和合作临床试验。在亚太地区，肿瘤领域的强劲资本投入，以及私立医院和研究中心数量的不断增长，推动了对先进治疗方法和可在分级诊疗环境中部署的紧凑型系统的需求。区域製造倡议和官民合作关係也进一步影响采购决策。这些区域模式凸显了製定灵活的商业策略的必要性，这些策略需要适应报销政策的实际情况、基础设施的限制以及长期的培训承诺。

竞争格局分析表明，供应商差异化和采购标准是由技术整合、服务模式和临床伙伴关係决定的。

设备供应商之间的竞争日益取决于技术差异化、卓越服务以及临床证据的协作创造。领先的供应商正在投资于互通性框架、云端规划解决方案和自适应交付能力，以提供超越硬体本身的综合提案主张。与学术中心和临床网路的伙伴关係有助于加速检验研究，并将技术优势转化为指南层级的临床实践。服务模式也随之发展，包括基于结果的维护合约和效能保证，从而使供应商的奖励与设施的运作和吞吐量目标保持一致。

规模较小的专业供应商专注于特定模式和改造解决方案，以延长现有设备的使用寿命；而规模较大的全球性公司则更重视规模、监管经验和广泛的服务网络。策略性收购和合作继续被用来弥补能力缺口，尤其是在软体、影像处理和粒子治疗领域。对于采购者而言，供应商评估越来越重视生命週期支援、合格的培训项目以及透明的软体更新和合规蓝图。在这种竞争激烈的环境中，差异化体现在已证实的临床疗效、可预测的服务经济性以及融入复杂的医院IT和影像处理生态系统的能力。

为医疗保健领导者提供切实可行的建议，以使其采购、培训和服务策略与临床目标和营运韧性保持一致。

产业领导者应采取多管齐下的策略，使技术投资与临床目标和财务限制保持一致。首先，优先选择提供模组化升级路径和开放互通性的平台，以保护资本投资并简化与电子健康记录和影像系统的整合。其次，投资于培训计划，提升物理学家、剂量师和治疗师的技能，使其能够充分利用自动化、自适应规划和立体定位功能，从而最大限度地提高效率和患者安全。第三，协商服务合同，强调可衡量的正常运作承诺、可预测的备件供应以及本地技术人员认证，以降低生命週期内的不确定性。

此外，相关人员应与研究中心建立伙伴关係，共同製定方案并收集真实世界证据，以支持新适应症的发展和医保报销的讨论。在进行大规模部署之前，应优先进行试点项目，以检验临床和营运效益，并纳入风险分担条款，协调供应商和医疗服务提供者之间的奖励。最后，应积极维护供应链紧急应变计画，包括关键零件的多供应商采购，并考虑在当地组装和维护，以最大限度地减少全球贸易中断的影响。实施这些措施将使各机构能够在改善临床疗效的同时，保障财务稳健和业务永续营运。

采用透明的混合方法研究途径，结合临床文献综述、相关人员访谈和设备性能分析，确保研究结果的可重复性。

本分析的研究方法结合了对同行评审的临床文献、监管文件、技术白皮书和设备性能报告的系统性回顾，以及对临床医生、医学物理学家、采购人员和服务经理的访谈。研究将定性见解与设备规格、已发表的临床试验结果和已记录的服务模式进行交叉比对，以全面了解设备的技术能力和运行限制。研究特别关注了近期关于自适应放射治疗、立体定位技术和粒子治疗结果的同侪审查证据，并将设备能力置于既定的临床路径中进行分析。

供应商文件和安装案例研究有助于评估维护策略和售后支持，而当地监管指南和报销政策简报则有助于理解推广障碍。保密访谈提供了关于采购週期、训练负担和停机容忍度的真实观点。研究方法强调可重复性和资讯来源检验，必要时会与多个独立资讯来源进行交叉核对，以减少偏差。这种混合方法的调查方法产生了可操作的见解，兼顾了临床细微差别和实际操作考量。

简洁的结论强调，需要平衡临床创新、生命週期经济和服务韧性，以实现癌症治疗的永续改善。

总之，放射治疗设备的采购和部署正处于曲折点，必须兼顾技术先进性、操作实用性和长期可维护性。影像导引、自适应计划和紧凑型治疗系统的进步为改善临床疗效和患者体验提供了明确的机会。然而，要实现这些益处，需要采购委员会、临床团队和服务机构之间进行有意识的协调，以应对资金、培训和监管方面的需求。

展望未来，采用模组化、可互通技术、投资于员工发展并达成稳健服务协议的机构，将更有能力应对不断变化的贸易政策以及报销和基础设施方面的区域差异。与研究机构建立策略伙伴关係，并专注于产生真实世界证据，可以进一步增强临床和商业性提案。采取严谨的技术应用方法——将临床优先事项与生命週期经济学和供应链韧性相结合——可以帮助医疗服务提供者在保持未来创新灵活性的同时，提供更高价值的医疗服务。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 引进人工智慧实现即时自适应放射治疗协调
  • 整合磁振造影引导的线性加速系统，以增强治疗过程中软组织的视觉化效果
  • 全球对用于治疗儿童和复杂癌症的质子治疗中心的投资增加
  • 开发一种旨在缩短治疗时间和减少对健康组织损伤的FLASH放射治疗通讯协定。
  • 拓展立体定位放射治疗方案，以更精准地针对寡转移性癌症。
  • 推出一款紧凑型行动线性加速器，专为偏远地区的照护现场放射治疗而设计。
  • 越来越多地使用云端基础的治疗计划平台，并利用高级分析功能进行远端协作。
  • 即时肿瘤追踪技术的进步提高了精度并最大限度地减少了辐射暴露

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 放射治疗设备市场：依技术划分

  • 近距离放射治疗
    • 高剂量率
    • 低剂量率
  • 线性加速器
    • 高能量
    • 低能耗
  • 质子治疗
  • 立体定位放射学系统

第九章：依最终用户分類的放射治疗设备市场

  • 门诊手术中心
    • 医院相关中心
    • 独立中心
  • 癌症研究中心
    • 政府研究机构
    • 私人研究机构
  • 医院
    • 私立医院
    • 公立医院

第十章 放射治疗设备市场：依应用领域划分

  • 大脑和神经系统
    • 常规放疗
    • 立体放射线手术
  • 胸部
    • 外樑
    • 手术过程中
  • 肺
    • 外樑
    • 立体定位躯干 RT
  • 摄护腺
    • 近距离放射治疗
    • 外樑

第十一章 各地区的放射治疗设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章 放射治疗设备市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章：各国放射治疗设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Siemens Healthineers AG
    • Elekta AB
    • Accuray Incorporated
    • ViewRay Incorporated
    • Ion Beam Applications SA
    • Mevion Medical Systems, Inc.
    • Brainlab AG
    • Sumitomo Heavy Industries, Ltd.
    • Hitachi, Ltd.
    • Best Theratronics Ltd.
Product Code: MRR-02026C4C95C5

The Radiation Therapy Equipment Market is projected to grow by USD 14.63 billion at a CAGR of 7.37% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 8.28 billion
Estimated Year [2025] USD 8.89 billion
Forecast Year [2032] USD 14.63 billion
CAGR (%) 7.37%

A concise introduction framing the converging clinical, technological, and operational forces reshaping radiation therapy equipment procurement and adoption

The radiation therapy landscape is undergoing a period of concentrated technical refinement and clinical integration, driven by advances in imaging, planning algorithms, and delivery platforms. Providers are prioritizing equipment that improves precision, reduces treatment times, and integrates with multidisciplinary care pathways. As care delivery shifts toward value-based models, clinical teams require devices that not only meet stringent efficacy and safety standards but also enable workflow efficiencies and patient experience improvements. Amidst tighter capital allocation and heightened regulatory scrutiny, strategic procurement decisions increasingly weigh lifecycle serviceability, interoperability, and demonstrable clinical benefit.

Concurrently, research programs and academic centers continue to push modality boundaries, exploring dose escalation strategies, adaptive treatment approaches, and the therapeutic potential of novel particles. This research momentum is complemented by a more informed patient population and referring physicians who expect clear evidence of outcomes and toxicity mitigation. Given these dynamics, executives and clinical leaders must synthesize technological capability with operational readiness and reimbursement realities when evaluating upgrades or new installations. Clear alignment between clinical goals and equipment selection will determine whether institutions maximize clinical outcomes while preserving financial sustainability.

How adaptive imaging, compact delivery platforms, AI-enabled planning, and service resilience are collectively reshaping clinical pathways and procurement priorities

Several transformative shifts are redefining the radiation therapy ecosystem and the way care is planned, delivered, and evaluated. First, the maturation of image-guided and adaptive radiotherapy workflows enables highly personalized treatments that adjust to anatomical changes across a course of care, thus altering equipment requirements and demand for integrated imaging capability. Second, the emergence of compact and cost-optimized platforms expands access to community settings while stimulating competition based on service models and total cost of ownership rather than capital price alone.

Third, computational advances-most notably in treatment planning automation and AI-assisted contouring-are changing workforce skill mixes and highlight the need for vendors to provide software updates and validation frameworks. Fourth, patient-centric design and reduced fractionation regimens are increasing throughput expectations, pushing institutions to balance speed with precision. Lastly, supply chain resilience and aftermarket service strategies have taken on heightened importance as providers prioritize uptime and predictable maintenance costs. Together, these shifts compel stakeholders to re-evaluate clinical pathways, procurement criteria, and vendor partnerships to remain clinically relevant and operationally efficient.

Assessing the operational consequences of recent tariff policies and how supply diversification and local servicing strategies can mitigate procurement disruption

The introduction of new tariff measures originating from trade policy adjustments has introduced a cascade of operational considerations for healthcare providers and technology suppliers. Import duties on select components and finished radiotherapy systems have the potential to raise acquisition costs for equipment that is manufactured abroad or reliant on internationally sourced subsystems. In response, procurement teams are reassessing total cost of ownership calculations and placing greater emphasis on modular architectures that permit phased upgrades, local serviceability, and parts interchangeability to mitigate exposure to cross-border price volatility.

Manufacturers and distributors are adapting by diversifying supplier networks, localizing final assembly where feasible, and renegotiating service contracts to preserve predictable lifecycle economics for customers. Clinical planners and capital committees must therefore anticipate longer lead times for certain configurations and prioritize compatibility with existing infrastructure to avoid costly retrofits. On the positive side, tariffs can accelerate strategies that strengthen domestic manufacturing capabilities and aftermarket ecosystems, creating opportunities for localized maintenance hubs and training programs. Ultimately, the cumulative impact of these trade measures will be felt across procurement timelines, vendor selection frameworks, and long-term maintenance planning, requiring coordinated responses from clinical, financial, and supply chain stakeholders.

Key segmentation insights linking technology modalities, healthcare delivery settings, and clinical applications to prioritize investments and operational planning

Understanding segmentation across technology, end user, and application provides a structured lens to evaluate product development priorities and adoption pathways. When technologies are considered, modalities such as brachytherapy-distinguishing high dose rate and low dose rate approaches-alongside linear accelerators differentiated by high energy and low energy configurations, proton therapy, and stereotactic systems each present distinct clinical trade-offs and capital profiles. These technology distinctions influence not only clinical indication suitability but also infrastructure requirements such as shielding, imaging integration, and room footprint, which in turn affect deployment timelines and multidisciplinary coordination requirements.

From an end user perspective, ambulatory surgical centers-comprising both hospital-affiliated centers and standalone centers-operate under different staffing, reimbursement, and throughput models compared with cancer research centers, which are further categorized into government research institutes and private research institutes, and hospitals, where private hospitals and public hospitals have divergent procurement governance and budget cycles. These differences shape purchase considerations, service level expectations, and training investments. Application segmentation across disease sites such as brain and nervous system treatments, where conventional radiotherapy and stereotactic radiosurgery play distinct roles, breast cancer managed via external beam and intraoperative strategies, lung cancer treated with external beam and stereotactic body radiotherapy, and prostate cancer approached through brachytherapy and external beam modalities, clarifies clinical workflow impacts and device feature priorities. Mapping technologies to end users and applications reveals where integration, clinical evidence generation, and specialized service support are most needed to drive adoption and optimize patient outcomes.

How regional reimbursement, infrastructure investment, and service networks across the Americas, Europe Middle East & Africa, and Asia-Pacific shape equipment adoption and partnership models

Regional dynamics influence adoption patterns, regulatory pathways, and partnership models across the globe. In the Americas, reimbursement frameworks, high concentration of advanced cancer centers, and a trend toward consolidations among hospital systems drive demand for scalable, high-throughput platforms that support complex indications. This region also places a premium on service networks and rapid response for equipment downtime, which shapes vendor selection and aftermarket strategies.

Across Europe, the Middle East & Africa, diverse regulatory landscapes and variable infrastructure investment levels result in a heterogeneous adoption curve where high-income markets prioritize cutting-edge modalities and lower-resource settings focus on cost-effective, durable platforms with strong local service support. Cross-border regulatory harmonization efforts and regional centers of excellence facilitate knowledge transfer and collaborative clinical trials. In the Asia-Pacific region, robust capital investment in cancer care combined with a growing number of privately funded hospitals and research centers propels demand for both advanced modalities and compact systems that can be deployed in tiered healthcare settings. Local manufacturing initiatives and public-private partnerships further influence procurement decisions. These regional patterns underscore the need for flexible commercial strategies that adapt to reimbursement realities, infrastructure constraints, and long-term training commitments.

Competitive landscape analysis showing how technology integration, service models, and clinical partnerships define vendor differentiation and procurement criteria

Competitive dynamics among equipment providers are increasingly defined by a combination of technological differentiation, service excellence, and collaborative clinical evidence generation. Leading vendors invest in interoperability frameworks, cloud-enabled planning solutions, and adaptive delivery capabilities to offer an integrated value proposition that extends beyond the hardware. Partnerships with academic centers and clinical networks accelerate validation studies and help translate technological advantages into guideline-level clinical practice. Service models have evolved to include outcome-based maintenance contracts and performance guarantees that align vendor incentives with institutional uptime and throughput targets.

Smaller and niche suppliers focus on specialized modalities or retrofit solutions that extend the life of installed bases, while larger global corporations emphasize scale, regulatory experience, and expansive service footprints. Strategic acquisitions and alliances continue to be a lever for filling capability gaps, particularly in software, imaging, and particle therapy domains. For purchasers, vendor evaluation now prioritizes lifecycle support, credentialed training programs, and transparent roadmaps for software updates and regulatory compliance. These competitive behaviors create an environment where differentiation is measured by demonstrable clinical impact, predictable service economics, and the ability to integrate into complex hospital IT and imaging ecosystems.

Actionable recommendations for healthcare leaders to align procurement, training, and service strategies with clinical goals and operational resilience

Industry leaders should adopt a multi-pronged strategy to align technological investments with clinical objectives and fiscal constraints. First, prioritize platforms that offer modular upgrade paths and open interoperability to protect capital investments and simplify integration with electronic health records and diagnostic imaging systems. Second, invest in training initiatives that upskill physicists, dosimetrists, and therapists to fully leverage automation, adaptive planning, and stereotactic delivery capabilities, thereby maximizing throughput and patient safety. Third, negotiate service agreements that emphasize measurable uptime commitments, predictable spare parts availability, and local technician certification to reduce lifecycle uncertainty.

Additionally, stakeholders should pursue partnerships with research centers to co-develop protocols and real-world evidence that support new indications and reimbursement discussions. Emphasize pilot programs that validate clinical and operational benefits in situ before large-scale rollouts, and incorporate risk-sharing clauses to align vendor and provider incentives. Finally, maintain active supply chain contingency planning that includes multi-sourcing of critical components and consideration of local assembly or maintenance hubs to minimize exposure to global trade disruptions. By implementing these measures, organizations can enhance clinical outcomes while protecting financial resilience and operational continuity.

A transparent mixed-methods research approach combining clinical literature review, stakeholder interviews, and device performance analysis to ensure reproducible insights

The research underpinning this analysis combined a systematic review of peer-reviewed clinical literature, regulatory filings, technical white papers, and device performance reports with targeted interviews of clinicians, medical physicists, procurement leads, and service managers. Qualitative insights were triangulated with equipment specifications, published clinical trial outcomes, and documented service models to ensure a comprehensive understanding of both technological capabilities and operational constraints. Particular attention was paid to recent peer-reviewed evidence on adaptive radiotherapy, stereotactic techniques, and particle therapy outcomes to contextualize device capabilities within established clinical pathways.

Vendor documentation and installation case studies informed assessments of maintenance strategies and aftermarket support, while regional regulatory guidance and reimbursement policy briefings shaped the interpretation of adoption barriers. Confidential interviews provided real-world perspectives on procurement cycles, training burdens, and downtime tolerance. The methodology emphasized reproducibility and source validation, and where appropriate, findings were cross-checked against multiple independent sources to reduce bias. This mixed-methods approach yields actionable insights that balance clinical nuance with pragmatic operational considerations.

A concise conclusion emphasizing the need to balance clinical innovation, lifecycle economics, and service resilience to achieve sustainable improvements in cancer care

In conclusion, radiation therapy equipment procurement and deployment are at an inflection point where technological sophistication must be balanced with operational pragmatism and long-term serviceability. Advancements in image guidance, adaptive planning, and compact delivery systems present clear opportunities to improve clinical outcomes and patient experience. However, realizing these benefits requires deliberate alignment across procurement committees, clinical teams, and service organizations to manage capital, training, and regulatory demands.

Looking ahead, organizations that adopt modular, interoperable technologies, invest in workforce development, and negotiate robust service arrangements will be better positioned to navigate trade policy shifts and regional variances in reimbursement and infrastructure. Strategic partnerships with research institutions and a focus on generating real-world evidence will further strengthen clinical and commercial propositions. By taking a disciplined approach to technology adoption-one that integrates clinical priorities with lifecycle economics and supply chain resilience-providers can deliver higher-value care while preserving flexibility for future innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of artificial intelligence for real time adaptive radiation therapy treatment adjustments
  • 5.2. Integration of MRI guided linear accelerator systems for enhanced soft tissue visualization during treatment
  • 5.3. Rising investments in proton beam therapy centers for pediatric and complex cancer cases worldwide
  • 5.4. Development of FLASH radiotherapy protocols aimed at reducing treatment time and healthy tissue damage
  • 5.5. Expansion of stereotactic body radiotherapy solutions targeting oligometastatic cancers with higher precision
  • 5.6. Emergence of compact mobile linear accelerators designed for point of care radiotherapy in remote locations
  • 5.7. Growing use of cloud based treatment planning platforms with advanced analytics for remote collaboration
  • 5.8. Advancements in real time tumor tracking technologies to improve accuracy and minimize radiation exposure

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Radiation Therapy Equipment Market, by Technology

  • 8.1. Brachytherapy
    • 8.1.1. High Dose Rate
    • 8.1.2. Low Dose Rate
  • 8.2. Linear Accelerators
    • 8.2.1. High Energy
    • 8.2.2. Low Energy
  • 8.3. Proton Therapy
  • 8.4. Stereotactic Systems

9. Radiation Therapy Equipment Market, by End User

  • 9.1. Ambulatory Surgical Centers
    • 9.1.1. Hospital-Affiliated Centers
    • 9.1.2. Standalone Centers
  • 9.2. Cancer Research Centers
    • 9.2.1. Government Research Institutes
    • 9.2.2. Private Research Institutes
  • 9.3. Hospitals
    • 9.3.1. Private Hospitals
    • 9.3.2. Public Hospitals

10. Radiation Therapy Equipment Market, by Application

  • 10.1. Brain And Nervous System
    • 10.1.1. Conventional RT
    • 10.1.2. Stereotactic Radiosurgery
  • 10.2. Breast
    • 10.2.1. External Beam
    • 10.2.2. Intraoperative
  • 10.3. Lung
    • 10.3.1. External Beam
    • 10.3.2. Stereotactic Body RT
  • 10.4. Prostate
    • 10.4.1. Brachytherapy
    • 10.4.2. External Beam

11. Radiation Therapy Equipment Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Radiation Therapy Equipment Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Radiation Therapy Equipment Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Siemens Healthineers AG
    • 14.3.2. Elekta AB
    • 14.3.3. Accuray Incorporated
    • 14.3.4. ViewRay Incorporated
    • 14.3.5. Ion Beam Applications S.A.
    • 14.3.6. Mevion Medical Systems, Inc.
    • 14.3.7. Brainlab AG
    • 14.3.8. Sumitomo Heavy Industries, Ltd.
    • 14.3.9. Hitachi, Ltd.
    • 14.3.10. Best Theratronics Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. RADIATION THERAPY EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. RADIATION THERAPY EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. RADIATION THERAPY EQUIPMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH DOSE RATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH DOSE RATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH DOSE RATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH DOSE RATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH DOSE RATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH DOSE RATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW DOSE RATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW DOSE RATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW DOSE RATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW DOSE RATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW DOSE RATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW DOSE RATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH ENERGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH ENERGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH ENERGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH ENERGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH ENERGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HIGH ENERGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW ENERGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW ENERGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW ENERGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW ENERGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW ENERGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LOW ENERGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROTON THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROTON THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROTON THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROTON THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROTON THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROTON THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITAL-AFFILIATED CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITAL-AFFILIATED CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITAL-AFFILIATED CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITAL-AFFILIATED CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITAL-AFFILIATED CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITAL-AFFILIATED CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STANDALONE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STANDALONE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STANDALONE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STANDALONE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STANDALONE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STANDALONE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GOVERNMENT RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GOVERNMENT RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CONVENTIONAL RT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CONVENTIONAL RT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CONVENTIONAL RT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CONVENTIONAL RT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CONVENTIONAL RT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CONVENTIONAL RT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY INTRAOPERATIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY INTRAOPERATIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY INTRAOPERATIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY INTRAOPERATIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY INTRAOPERATIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY INTRAOPERATIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC BODY RT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC BODY RT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC BODY RT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC BODY RT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC BODY RT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC BODY RT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRACHYTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY